13.55 | 10.55 – Exosome-based Digital PCR for FGFR Testing in Bladder Cancer

Time: 1:55 pm
day: Day One


  • A new therascreen workflow is developed using liquid biopsy and digital PCR
  • Exosome Diagnostics GmbH (Sample and Extraction Technology),
    STRATIFYER GmbH (EU Clinical Pathology Network) and QIAGEN (Assay
    Technology) collaborate on this project
  • First results of an ongoing clinical study on FGFR alterations are presented